Prenetics Global Limited
PRENASDAQHealthcare● Active
$20.00
+$0.14(+0.70%)
Market Cap$340007860
P/E Ratio—
52W High$23.63
52W Low$6.88
Prenetics Global Limited (PRE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PRE · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$1.14
Est. -$0.49 · -131.6%
Revenue
$0.04B
Est. $0.04B · -2.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
PRE reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 11, 2026 | -$0.84 | — | — | — | $0.05B | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.49 | -$1.14 | -131.6% | $0.04B | $0.04B | -2.3% |
| ▲ Q1 FY2026 | Feb 18, 2026 | -$0.49 | -$0.27 | +44.9% | $0.04B | $0.03B | +9.5% |
| ▲ Q4 FY2025 | Nov 10, 2025 | -$0.55 | -$0.41 | +25.4% | $0.02B | $0.04B | -38.5% |
| ▼ Q3 FY2025 | Sep 12, 2025 | -$0.71 | -$0.82 | -15.5% | $0.02B | $0.02B | -18.5% |
| ▼ Q2 FY2025 | Jun 12, 2025 | -$0.77 | -$0.80 | -3.9% | $0.02B | $0.01B | +44.3% |
| ▼ Q1 FY2025 | Mar 5, 2025 | -$0.72 | -$1.29 | -78.6% | $0.01B | $0.01B | -12.6% |
| ▲ Q4 FY2024 | Nov 27, 2024 | -$0.93 | -$0.88 | +5.4% | $0.01B | $0.01B | -15.5% |
Q3 FY2026
Sep 11, 2026
EPS Actual
—
EPS Est.
-$0.84
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$1.14
EPS Est.
-$0.49
EPS Surpr.
-131.6%
Revenue
$0.04B
Q1 FY2026
Feb 18, 2026Beat
EPS Actual
-$0.27
EPS Est.
-$0.49
EPS Surpr.
+44.9%
Revenue
$0.04B
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
-$0.41
EPS Est.
-$0.55
EPS Surpr.
+25.4%
Revenue
$0.02B
Q3 FY2025
Sep 12, 2025Miss
EPS Actual
-$0.82
EPS Est.
-$0.71
EPS Surpr.
-15.5%
Revenue
$0.02B
Q2 FY2025
Jun 12, 2025Miss
EPS Actual
-$0.80
EPS Est.
-$0.77
EPS Surpr.
-3.9%
Revenue
$0.02B
Q1 FY2025
Mar 5, 2025Miss
EPS Actual
-$1.29
EPS Est.
-$0.72
EPS Surpr.
-78.6%
Revenue
$0.01B
Q4 FY2024
Nov 27, 2024Beat
EPS Actual
-$0.88
EPS Est.
-$0.93
EPS Surpr.
+5.4%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.29 | $0.32 | $0.34 | 1 |
| Q3 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2027 | $-0.46 | $-0.43 | $-0.39 | 1 |
| Q1 FY2027 | $-0.51 | $-0.47 | $-0.43 | 1 |
| Q4 FY2026 | $-0.83 | $-0.77 | $-0.70 | 1 |
| Q3 FY2026 | $-0.84 | $-0.78 | $-0.70 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2026 | $0.0B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -131.6% | $17.57 | $17.59 | +0.11% |
| ▲ Q1 FY2026 | Feb 18, 2026 | +44.9% | $21.74 | $20.06 | -7.73% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +25.4% | $12.34 | $11.89 | -3.65% |
| ▼ Q3 FY2025 | Sep 12, 2025 | -15.5% | $8.86 | $10.07 | +13.66% |
| ▼ Q2 FY2025 | Jun 12, 2025 | -3.9% | $7.60 | $8.02 | +5.53% |
| ▼ Q1 FY2025 | Mar 5, 2025 | -78.6% | $4.82 | $4.79 | -0.62% |
| ▲ Q4 FY2024 | Nov 27, 2024 | +5.4% | $4.50 | $4.43 | -1.56% |
| ▲ Q3 FY2024 | Sep 27, 2024 | +83.9% | $4.19 | $4.12 | -1.67% |
Q2 FY2026+0.11%
Report Date
May 14, 2026
EPS Beat/Miss
-131.6%
Price Before
$17.57
Price After
$17.59
Q1 FY2026-7.73%
Report Date
Feb 18, 2026
EPS Beat/Miss
+44.9%
Price Before
$21.74
Price After
$20.06
Q4 FY2025-3.65%
Report Date
Nov 10, 2025
EPS Beat/Miss
+25.4%
Price Before
$12.34
Price After
$11.89
Q3 FY2025+13.66%
Report Date
Sep 12, 2025
EPS Beat/Miss
-15.5%
Price Before
$8.86
Price After
$10.07
Q2 FY2025+5.53%
Report Date
Jun 12, 2025
EPS Beat/Miss
-3.9%
Price Before
$7.60
Price After
$8.02
Q1 FY2025-0.62%
Report Date
Mar 5, 2025
EPS Beat/Miss
-78.6%
Price Before
$4.82
Price After
$4.79
Q4 FY2024-1.56%
Report Date
Nov 27, 2024
EPS Beat/Miss
+5.4%
Price Before
$4.50
Price After
$4.43
Q3 FY2024-1.67%
Report Date
Sep 27, 2024
EPS Beat/Miss
+83.9%
Price Before
$4.19
Price After
$4.12
Avg Beat Reaction-3.65%
Avg Miss Reaction+4.67%
Beat Rate4 / 8 quarters
Largest Move+13.66% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PRE ends December
Prenetics Global Limited (PRE) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-1.14 — missing the analyst consensus of $-0.49 by -131.6%. The next PRE earnings date is expected around September 1, 2026.
Each quarter, investors track PRE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PRE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PRE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PRE earnings · 5 questionsPrenetics Global Limited's next earnings report is expected around September 1, 2026. PRE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PRE historically reports after market close (AMC).
PRE earnings datewhen is PRE earningsPRE next earnings datewhen does PRE report earningsPRE earnings calendar
▸ Source: FMP · Prenetics Global Limited SEC filings · US GAAP · Prenetics Global Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026